Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.1%

5 terminated out of 45 trials

Success Rate

82.1%

-4.4% vs benchmark

Late-Stage Pipeline

22%

10 trials in Phase 3/4

Results Transparency

35%

8 of 23 completed with results

Key Signals

8 with results82% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (8)
P 1 (1)
P 2 (6)
P 3 (9)
P 4 (1)

Trial Status

Completed23
Unknown7
Terminated5
Recruiting4
Not Yet Recruiting3
Withdrawn3

Trial Success Rate

82.1%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT06070350Phase 3RecruitingPrimary

Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

NCT07695129Not Yet RecruitingPrimary

Hemorrhagic Shock in Orthopedic Fractures

NCT07218185Not Yet Recruiting

Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage

NCT07105904Completed

Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery

NCT04684719Phase 3CompletedPrimary

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

NCT02880163Not ApplicableRecruitingPrimary

REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam

NCT07129031Phase 3Not Yet Recruiting

Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock

NCT05081063Phase 3CompletedPrimary

Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients

NCT07053163Not ApplicableCompleted

Low Dose of Norepinephrine Within 24-Hour Mortality in Traumatic Patient With Hemorrhagic Shock

NCT06270615Completed

Prospective Validation of the SHOCKMATRIX Hemorrhage Predictive Model

NCT06670248Recruiting

Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients

NCT03469947Phase 3CompletedPrimary

California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA

NCT06311903Not ApplicableRecruiting

Norepinephrine in Preperiod of Hypotensive Resuscitation in Hemorrhagic Shock

NCT03402035CompletedPrimary

Shock, Whole Blood, and Assessment of TBI S.W.A.T. (LITES TO 2)

NCT04149171Phase 3CompletedPrimary

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage

NCT02071290Not ApplicableCompletedPrimary

Effect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic Shock

NCT01221389Phase 4WithdrawnPrimary

Study Using Plasma for Patients Requiring Emergency Surgery

NCT00581204CompletedPrimary

Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans

NCT02821364Not ApplicableWithdrawnPrimary

Philadelphia Immediate Transport in Penetrating Trauma Trial

NCT04497155Completed

Prehospital Norepinephrine and Early Mortality in Traumatic Shock

Scroll to load more

Research Network

Activity Timeline